Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
B D M Ratnayaka Department of Neonatal
Medicine, City Hospital, Nottingham NG5 1PB
Baclofen is a skeletal muscle relaxant used for the
relief of chronic severe spasticity resulting from disorders such as
multiple sclerosis or traumatic injury to the spinal cord. We report
convulsions in a 7 day old girl who had been exposed to baclofen during
intrauterine life.
A paraplegic mother had been taking baclofen 20 mg four times daily
(Lioresal, Novartis, Surrey), oxybutanin 3 mg three times daily,
and trimethoprim 100 mg daily, which she continued throughout her
pregnancy. The pregnancy was uneventful, but the baby was delivered by
ventouse extraction owing to fetal tachycardia. The Apgar score was 10 at one and five minutes (cord pH: arterial 7.33, venous 7.3).
Seven days later the baby was admitted with generalised convulsions. In
retrospect the mother had noticed abnormal movements from the second
day after birth. Investigations included a full septic screen for
bacteriology and virology; a full blood count; serum electrolytes;
liver function tests; a metabolic screen of blood, urine, and
cerebrospinal fluid; urine for toxicology; and cranial ultrasonography.
All gave negative results. The convulsions did not respond to
phenobarbitone, phenytoin, clonazepam, lignocaine, or pyridoxine, which
were tried according to our hospital's guidelines for the management
of neonatal seizures. The baby received broad spectrum antibiotics
until the cultures gave negative results. Electroencephalography on day
11 showed prolonged episodes of epileptic activity.
We thought that the convulsions could be due to withdrawal of baclofen.
Baclofen, 1 mg/kg daily in four divided doses, was started. Thirty
minutes after the first dose the convulsions stopped. Baclofen was
withdrawn slowly over the next two weeks. Magnetic resonance imaging of
the brain on day 17 suggested a short hypoxic ischaemic insult during
the perinatal period.
Because the baby was in good condition at birth and because the
convulsions were controlled within 30 minutes of starting baclofen, we
concluded that the convulsions had been caused by its withdrawal. The
change shown by the magnetic resonance image may have been secondary to
the convulsions.
In adults the half life of baclofen is 2-6 hours (mean 3.5 hours). A
previous report of baclofen overdose showed a secondary increase in
baclofen concentrations into the therapeutic range after an initial
decrease, probably due to its slow release from the central
nervous system and lipid stores.5 This may explain the
delay in presentation of our patient.
Convulsions after withdrawal of baclofen are well reported in
adults.1-4 Convulsions after withdrawal of exposure to
baclofen during intrauterine life have not been reported; this is the
first such report to the Committee on Safety of Medicines.
Footnotes
Competing interests: None declared.
References
| 1. | Barker I, Grant IS. Convulsions after abrupt withdrawal of baclofen. Lancet 1982; 2: 556-557[Medline]. |
| 2. | Hyser CL, Drake ME. Status epilepticus after baclofen withdrawal. J Natl Med Assoc 1984; 76: 533-538[Medline]. |
| 3. |
Kofler M, Lewis AA.
Prolonged seizure activity after baclofen withdrawal.
Neurology
1992;
42:
697-698 |
| 4. |
Terence CF, Formm GH.
Complications of baclofen withdrawal.
Arch Neurol
1981;
38:
588-589 |
| 5. |
Lipscomb DJ, Meredith TJ.
Baclofen overdose.
Postgrad Med J
1980;
56:
108-109 |
Read all Rapid Responses